Drug repurposing screen for the rare disease ataxia-telangiectasia

Drug repurposing screen for the rare disease ataxia-telangiectasia

Ataxia Telangiectasia (A-T) is a rare, autosomal recessive genetic disorder characterized by a variety of symptoms, including progressive neurodegeneration, telangiectasia, immunodeficiency, and an increased susceptibility to cancer. It is caused by bi-allelic mutations impacting a gene encoding a s...

Full description

Saved in:
Bibliographic Details
Main Authors: Namrata Jayanth, Gurvan Mahé, Matthew Campbell, Mike Lipkin, Shushant Jain, Rhea van de Bospoort, Jennifer Thornton, Brad Margus, David F. Fischer
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:SLAS Discovery
Subjects:
Drug repurposing screen
HTS
DNA damage
Rare disease
Ataxia-telangiectasia
Neurodegeneration
Online Access:http://www.sciencedirect.com/science/article/pii/S2472555224000625
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items